The MTOR inhibitor rapamycin mitigates perforant pathway neurodegeneration and synapse loss in a mouse model of Early-Stage Alzheimer-Type tauopathy
Before considering them, I look at: Sleep architecture Protein intake Resistance training stimulus Vitamin D Iron status Thyroid function Testosterone and SHBG if clinically indicated ApoB and metabolic risk Body composition trends If those are not optimised, peptides are premature
Furthermore, risk of deficiencies of key nutrients that are essential cofactors, such as folate and B12, for methylation and conversion of homocysteine may increase in prevalence postmenopausally, in response to disruptions to oestrogen levels (Vasquez-Lorenete et al., 2022)
This disruption of immune function can contribute to developing neurological disorders, including ASD
Pigmentation changes PT-141 was originally studied for its skin-darkening effects
Short-Term Progress One of the first questions people ask is, How soon will I see a difference? While everyones body is different, many of our clients start to notice changes within the first few weeks of treatment
